Llwytho...
Single-Hormone Artificial Pancreas Use in Diabetes: Clinical Efficacy and Remaining Challenges
IN BRIEF Artificial pancreas systems are rapidly developing and constitute the most promising technology for insulin-requiring diabetes management. Single-hormone systems (SH-AP) that deliver only insulin and have a hybrid design that necessitates patients’ interventions around meals and exercise ar...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Diabetes Spectr |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Diabetes Association
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695251/ https://ncbi.nlm.nih.gov/pubmed/31462874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds18-0094 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|